Sedana Medical AB (SEDANA) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.009x

Based on the latest financial reports, Sedana Medical AB (SEDANA) has a cash flow conversion efficiency ratio of -0.009x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-7.71 Million ≈ $-829.29K USD) by net assets (Skr888.45 Million ≈ $95.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Sedana Medical AB (SEDANA) market capitalisation for the company's overall valuation and market capitalisation.

Sedana Medical AB - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Sedana Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sedana Medical AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sedana Medical AB ranked by their cash flow conversion efficiency. Explore cash flow quality index of Sedana Medical AB to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Chung Lien Transportation Co Ltd
TWO:5604
0.011x
Net Insight AB (publ)
ST:NETI-B
0.068x
China Silver Group Limited
F:2CS
0.015x
Captor Therapeutics S.A.
WAR:CTX
-0.346x
Purit Co. Ltd.
KQ:445180
0.022x
Patriot National Bancorp Inc
NASDAQ:PNBK
-0.063x
Bank of the James Financial Group
NASDAQ:BOTJ
0.024x
Fast Food Indonesia Tbk
JK:FAST
0.583x

Annual Cash Flow Conversion Efficiency for Sedana Medical AB (2016–2025)

The table below shows the annual cash flow conversion efficiency of Sedana Medical AB from 2016 to 2025. View Sedana Medical AB stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr900.78 Million
≈ $96.94 Million
Skr-12.78 Million
≈ $-1.38 Million
-0.014x -15.51%
2024-12-31 Skr958.23 Million
≈ $103.12 Million
Skr-11.77 Million
≈ $-1.27 Million
-0.012x +68.70%
2023-12-31 Skr970.00 Million
≈ $104.39 Million
Skr-38.06 Million
≈ $-4.10 Million
-0.039x +65.02%
2022-12-31 Skr1.03 Billion
≈ $110.75 Million
Skr-115.43 Million
≈ $-12.42 Million
-0.112x -199.71%
2021-12-31 Skr1.10 Billion
≈ $118.53 Million
Skr-41.22 Million
≈ $-4.44 Million
-0.037x -162.86%
2020-12-31 Skr551.09 Million
≈ $59.31 Million
Skr-7.85 Million
≈ $-844.35K
-0.014x +6.83%
2019-12-31 Skr569.38 Million
≈ $61.27 Million
Skr-8.70 Million
≈ $-936.28K
-0.015x +42.41%
2018-12-31 Skr217.81 Million
≈ $23.44 Million
Skr-5.78 Million
≈ $-621.90K
-0.027x -723.16%
2017-12-31 Skr116.40 Million
≈ $12.53 Million
Skr495.60K
≈ $53.33K
0.004x -97.74%
2016-12-31 Skr1.26 Million
≈ $135.81K
Skr238.00K
≈ $25.61K
0.189x --

About Sedana Medical AB

ST:SEDANA Sweden Medical Devices
Market Cap
$106.05 Million
Skr985.42 Million SEK
Market Cap Rank
#19036 Global
#331 in Sweden
Share Price
Skr9.92
Change (1 day)
+0.71%
52-Week Range
Skr7.93 - Skr13.62
All Time High
Skr107.10
About

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a syringe with a connection to fit the c… Read more